资讯

Lilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy

Eli Lilly has established itself as the market leader in obesity drugs in Europe, Asia and the Middle East and expects to ...

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes ...

Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped ...
Public Broadcasting Service (PBS)

FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes

The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing ...

Lupin gets U.S. FDA nod for generic of cancer drug Revlimid capsules

Lupin receives FDA approval for Lenalidomide Capsules, a generic version of Revlimid, for multiple myeloma treatment.